Veracyte | VCYT - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
34.33
Cambio Giornaliero
1.18 3.56%
Mensile
4.70%
Annuale
6.52%
Q2 Previsione
33.60




Spese Di Vendita E Di Amministrazione Cambiamento Data
Agenus USD 10.56M 13.04M 2025-12
Agilent USD 476M 48M 2025-12
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Illumina USD 283M 27M 2025-12
Intrexon USD 10.31M 41K 2024-06
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
Myriad Genetics USD 122.3M 6.7M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Siemens EUR 3.61B 489M 2025-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Veracyte USD 43.31M 8.43M 2025-12
Waters USD 240.01M 25.78M 2025-12